Patent EP4626864A1: Diamide Activators by Protego Biopharma
Summary
The European Patent Office has published patent application EP4626864A1, titled 'Diamide Activators', filed by Protego Biopharma, Inc. The patent covers novel chemical compounds intended for use as IRE1/XBP1s activators.
What changed
The European Patent Office (EPO) has published patent application EP4626864A1, which details "LINEAR HETEROARYL DIAMIDE IRE1/XBP1S ACTIVATORS" developed by Protego Biopharma, Inc. The application includes extensive International Patent Classification (IPC) codes related to organic chemistry and pharmaceutical compositions, indicating a focus on novel chemical entities and their potential therapeutic applications.
This publication represents the granting of a patent for specific chemical compounds and their uses. While it does not impose direct compliance obligations on regulated entities in the same way as a rule or guidance, it establishes intellectual property rights for Protego Biopharma. Companies operating in the pharmaceutical sector, particularly those involved in drug discovery and development related to IRE1/XBP1 signaling pathways, should be aware of this patent to avoid potential infringement and to inform their own research and development strategies.
Source document (simplified)
LINEAR HETEROARYL DIAMIDE IRE1/XBP1S ACTIVATORS
Publication EP4626864A1 Kind: A1 Mar 11, 2026
Applicants
Protego Biopharma, Inc.
Inventors
LABAUDINIERE, Richard F., TAIT, Bradley Dean, QIU, Huang, PETRASSI, Hank Michael James, QIN, Bo
IPC Classifications
C07D 231/40 20060101AFI20250623BHEP C07D 285/08 20060101ALI20250623BHEP C07D 401/12 20060101ALI20250623BHEP C07D 401/14 20060101ALI20250623BHEP C07D 403/12 20060101ALI20250623BHEP C07D 405/12 20060101ALI20250623BHEP C07D 405/14 20060101ALI20250623BHEP C07D 471/04 20060101ALI20250623BHEP C07D 487/04 20060101ALI20250623BHEP C07D 491/056 20060101ALI20250623BHEP A61K 31/415 20060101ALI20250623BHEP A61K 31/433 20060101ALI20250623BHEP A61K 31/4355 20060101ALI20250623BHEP A61K 31/437 20060101ALI20250623BHEP A61K 31/4439 20060101ALI20250623BHEP A61K 31/497 20060101ALI20250623BHEP A61K 31/506 20060101ALI20250623BHEP A61P 1/00 20060101ALI20250623BHEP A61P 1/16 20060101ALI20250623BHEP A61P 3/10 20060101ALI20250623BHEP A61P 9/00 20060101ALI20250623BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.